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We characterized an autosomal-recessive syndrome of focal epilepsy, dysarthria, and mild to moderate intellectual disability in a con-
sanguineous Arab-Israeli family associated with subtle cortical thickening. We used multipoint linkage analysis to map the causative
mutation to a 3.2 Mb interval within 16p13.3 with a LOD score of 3.86. The linked interval contained 160 genes, many of which
were considered to be plausible candidates to harbor the disease-causing mutation. To interrogate the interval in an efficient and
unbiased manner, we used targeted sequence enrichment and massively parallel sequencing. By prioritizing unique variants that
affected protein translation, a pathogenic mutation was identified in TBC1D24 (p.F251L), a gene of unknown function. It is a member
of a large gene family encoding TBC domain proteins with predicted function as Rab GTPase activators. We show that TBC1D24 is
expressed early in mouse brain and that TBC1D24 protein is a potent modulator of primary axonal arborization and specification in
neuronal cells, consistent with the phenotypic abnormality described.The epilepsies and intellectual disabilities (ID) are clinically
heterogeneous groups of disorders each affecting about
3% of the population at some time in life. Intellectual
disability presents in association with seizures in around
21% of cases.1 The degree of comorbidity between epilepsy
and ID strongly suggests an overlap of underlying genetic
determinants. Traditionally, mutation identification in
epilepsy and ID has been driven by positional and func-
tional gene candidate approaches. Although mutations in
ion channel subunits have emerged as the most signifi-
cant cause of idiopathic epilepsies,2 no pattern for enrich-
ment of mutations in genes of a particular function has
emerged for ID or epilepsy associated with ID. For such
situations, genome-wide copy number profiling,3 system-
atic resequencing,4 and, most recently, targeted sequence
enrichment and next-generation sequencing5–7 are prov-
ing to be the most effective approaches for discovering
the disease-associated variation.
We examined a large Arab family from northern Israel
with epilepsy and ID (Figure 1A). Focal seizures with prom-
inent eye blinking and facial and limb jerking began at
around 2 months of age and persisted throughout life. The
patients described an aura with the sensation of the tongue
being anaesthetized. Convulsive seizures also occurred
but were generally controlled by antiepileptic medication.
Early motor and speech development was mildly delayed
in some children, and in adult life there was borderline
to moderate ID associated with mild dysarthria and ataxia.
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The Americancortical thickening, most obvious in the anteromesial
frontal areas (Figure 1B).
The pedigree structure with multiple consanguineous
unions suggested autosomal-recessive inheritance. For the
purpose of linkagemapping, eight samples were genotyped
(as indicated in Figure 1A) with the 250K Nsp Affymetrix
chip. The study was approved by the Tel Aviv Sourasky
Medical Center ethics committee. Informed consent was
obtained from participating subjects. The genotype calls
were produced with CRLMM,8 which is implemented in
the R statistical programming language OLIGO package. A
subset of 7406 SNPs with high heterozygosity (mean
heterozygosity¼ 0.48) was created for the linkagemapping
with the program Linkdatagen,9 setting the bin size to
0.5 cM. Genotyping errors were identified withMerlin.10,11
Multipoint linkage analysis was carried out with Merlin by
using a rare autosomal-recessive model with the following
parameters for the disease allele a and for normal allele
A: Pr(a) ¼ 0.0001, Pr(diseasejaa) ¼ 0.9999, Pr(diseasejAA
or Aa) ¼ 0.0001, reflecting a fully penetrant model. That
model identified a single candidate region encompassing
160 genes on chromosome 16, between rs1088638 and
rs9922740, LOD ¼ 3.86 (Figure 1C).
A custom 385K tiling microarray (Roche/Nimblegen)
was constructed with genomic DNA sequence correspond-
ing to the entire linked interval, excluding regions masked
by the Sequence Search and Alignment by Hashing Algo-
rithm12 (2.3 out of 3.2 Mb). This was used as a probe for
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Figure 1. Mapping and Identification of a Mutation in TBC1D24
(A) Pedigree showing evidence of likely autosomal-recessive inheritance and consanguinity. Individuals used in homozygosity mapping
are marked withM, the individual sequenced by next-generation sequencing is marked with S, and C/C, C/T, and T/T indicate TBC1D24
c.751 alleles. Solid squares indicate affected individuals.
(B) Axial MRI image of V-25 that we interpreted as showing thickened cortex in the frontal poles with loss of gray-white matter defini-
tion, consistent with a developmental malformation (arrows).
(C) Work flow for the identification of the mutation in TBC1D24: linkage homozygous-by-descent analysis (top) identified a single peak
on chromosome 16p13.3 covering 9cM (or 3.2 Mb); the entire sequence, excluding repeats, was tiled as indicated by the black sections
on the tile path; sequence coverage (bottom), determined by the number of times a base was covered by a sequence read, shows variation
over the 3.2 Mb interval.
(D) A schematic representation of the exonic structure of TBC1D24 and the domain structure of the TBC1D24 protein. The position of
the c.751C>T, p.F251L mutation within the TBC domain (translated from exon 2) is shown. Exons are indicated as boxes, with the
translated region shown in black. The TBC and TLD domains are shown.
(E) A portion of a CLUSTALWmultiple protein alignment of TBC1D24 orthologs shows that p.F251 (highlighted with gray background)
is conserved inmammals, chicken, fruit fly, mosquito, and a highly similar tyrosine (Y) substitution in zebra fish. Orthologs of TBC1D24
were identified by tblastn search, and the Homologene database and alignments were performed with the EBI CLUSTALW server.19
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Table 1. Summary of Unique Variants in Open Reading Frames
bp on Chr16a Gene RefSeq DNA Variant Predicted Protein Variant
625,295 C16orf13 NM_032366.3 and NM_001040160.1 c.406T>C and c.243T>C p.(L136P) and p.(S82P)
1,664,017 CRAMP1L NM_020825.3 c.3780C>T p.(G1260G)
1,756,740 MAPK8IP3 NM_015133.3 c.2952G>A p.(S984S)
1,809,941 HAGH NM_005326.4 c.390C>T p.(I130I)
2,486,901 TBC1D24 NM_020705.1 c.751T>C p.(F251L)
2,795,033 PRSS41 NM_001135086.1 c.856A>G p.(S286G)
a Base pair (bp) position is based on the UCSC Genome Browser hg18 (March 2006) reference sequence.from individuals V-18 and V-21 (Figure 1A; Nimblegen).5
Genomic DNA fragments were retrieved from individual
V-18 with an estimated mean 180-fold enrichment. These
DNA fragments were concatenated by ligation and sheared
by sonication to be converted to an Illumina GAII-compat-
ible library6 (GeneWorks). A single lane from the Illumina
GAII returned 8.8 3 106 65 bp reads (GeneWorks). Using
default parameters of the Phred/Phrap/Consed program
(version 19.0),13 we found that 2.7 3 106 (31%) of the
reads assembled to a repeat masked segment of the hg18
reference sequence corresponding to the linkage interval.
Coverage to a depth of at least one sequence read incorpo-
rated 95.51% of bases from open reading frames (ORFs) of
RefSeq genes included in the March 2006 (hg18) build
of the UCSC Genome Browser. A minimum of 10-fold
coveragewas achieved for 76.92%of bases in all ORFs in the
interval. Over the entire 3.2 Mb linkage interval, 89.93%
of bases were covered with at least one sequence read (see
Figure S1 available online). Coverage was biased against
sequences with high GC content and repeats, as defined by
Repeat Masker (p < 0.05 by c2 analysis; Table S1).
We identified 1029 single nucleotide variants, at a
minimum of 10-fold coverage, in which the variant base
was represented in at least 85% of reads. Of these variants,
102 were not represented in dbSNP130. These novel vari-
ants were categorized as ORF, splice site, 50UTR, 30UTR,
intronic, or intergenic based on their genomic context in
relation toknowngenes (Table S2).Variantswereprioritized
for analysis according to the order listed above, focusing on
mutations inORF or splice sites thatwere predicted to affect
translated sequences. This filtering removed all but six vari-
ants, and only three of these—one in TBC1D24 (c.751T>C,
p.F251L [NM_020705]), another in the alternatively spliced
C16orf13 (c.406C>T, p.L136P [NM_032366.3]), and a third
in PRSS41 (c.856A>G, p.S286G [NM_001135086.1])—were
predicted to result in amino acid changes (Table 1). Subse-
quent segregation analysis on an extended pedigree to that
originally used formapping led us to exclude the c.406C>T
change in C16orf13, which was not present in the obligate
carrier male IV-1 (Figure 1A). PRSS41 was shown to not be
expressed in the brain and to therefore be unlikely to con-
tribute to thephenotype (Figure S2).As a consequence, only
a single missense change, TBC1D24 (c.751T>C, p.F251L)The Americanremained (Figure 1D). This change was not present in 210
control chromosomes from a matched Arab population.
The following data support the proposition that the
TBC1D24 (c.751T>C, p.F251L) variant is pathogenic. First,
the phenylalanine (F) at position p.251 is conserved in
mammals and, to a lesser extent, in other vertebrate and
invertebrate species (Figure 1E). Second, we showed that
TBC1D24 is expressed in mouse embryonic stem cell-
derived neurons, cultured embryonic day 18.5 (E18.5)
mouse hippocampal neurons, and the developing mouse
brain (Figures S3A, S3B, andS3C, respectively). Collectively,
these expression profiles correlate high expression of
Tbc1d24 with terminal differentiation of neurons, which
is consistent with a gene influencing cortical development,
early-onset seizures, and ID. Third, to determine the
currently unknown role of the TBC1D24 protein, we over-
expressed the wild-type and mutant TBC1D24 proteins in
mouse E18.5 primary hippocampal neurons. Cellmorphol-
ogy in neurons overexpressing the TBC1D24 protein with
the p.F251L change did not differ noticeably from those
transfected only with green fluorescent protein (GFP).
However, the overexpression of the wild-type TBC1D24
protein significantly increased the length of primary axons,
as defined by Tau1 staining and the number of neurite
termini (p < 0.05 by Student’s two-tailed t test; Figures 2A
and 2B, respectively), at both 5 and 7 days posttransfection,
demonstrating increased arborization (Figure 2D). Further-
more,weobservedectopicaxonspecification incellsoverex-
pressing the wild-type protein (Figure 2C). Taken together,
these cell culture data suggest that TBC1D24protein is likely
to have an important role in normal human brain develop-
ment. Moreover, the absence of these effects in cells over-
expressing the p.F251L mutant suggests that this missense
change results in a loss of TBC1D24 protein function (Fig-
ure 2). These three lines of evidence demonstrate that the
TBC1D24 c.751T>C, p.F251L change represents the most
likely disease-causing mutation in this family.
The TBC domain protein family members that have
been characterized are Rab GTPase activators (GAPs) that
catalyze GTP hydrolysis, switching their cognate GTPase
from the active GTP-bound form to the inactive GDP-
bound form. In TBC1D24, the N-terminal TBC subdomain
lacks the crucial arginine and glutamine residues requiredJournal of Human Genetics 87, 371–375, September 10, 2010 373
Figure 2. TBC1D24 Is a Potent Modulator of Neuronal Cell Morphology and Primary Axon Specification
For all experiments: ED18.5 hippocampal neurons were isolated via established methods20 and then transfected with the Amaxa Mouse
Neuron Nucleofector kit (Lonza). Cells were transfected with 1 mg of the supplied pmaxGFP vector alone (control) or in addition to 2 mg
of either a commercially available expression vector RC210346 (NM_020705; OriGene Technologies) for the human TBC1D24 ORF
(TBC1D24WT) or the same RC210346 vector with the c.751T>C mutation introduced by site-directed mutagenesis (TBC1D24F251L).
Following transfection, neurons were plated onto poly-D-lysine (Sigma)-coated coverslips at a density of 1.25 3 105 cells per well in
Neurobasal media containing 2% (vol/vol) B27 (Invitrogen) and 10% fetal calf serum (FCS, Thermoscientific). Once cells were attached
(~4 hr), the FCS was removed and the cells were cultured for a further 3, 5, or 7 days, with half of the media changed every 4 days. Cells
were fixed with 4% paraformaldehyde for 15 min at room temperature and then permeabilized, and nonspecific antigens were blocked
with a solution of phosphate-buffered saline containing 1% Tween 20 (PBST) and 10% normal horse serum (Sigma). Primary antibodies
were incubated overnight at 4C at the following dilutions: chicken anti-MAP2 (1:2000, Chemicon, Millipore Bioscience Research
Products) to identify dendrites or mouse anti-Tau1 (1:2000, Chemicon) to identify axons. Either donkey anti-mouse-Alexa647 (Invitro-
gen) or donkey anti-chicken-Cy3 (Chemicon) secondary antibodies were used at a dilution of 1:800. Nuclei were stained with DAPI as
per the manufacturer’s protocol (Invitrogen). Coverslips were mounted with Slowfade antifade mountingmedia (Invitrogen). *p< 0.05,
**p < 0.01, ***p < 0.005 by Student’s two-tailed t test, assuming equal variances.
(A) Overexpression of TBC1D24WT but not TBC1D24F251L promotes axonal growth in cultured hippocampal neurons. Graph depicts
average length of primary axons 5 standard deviation (SD) from triplicate experiments measured with the ‘‘measure cumulative
distances’’ plugin for the ImageJ software package (National Institutes of Health), with at least 20measurementsmade for each treatment.
(B) Overexpression of TBC1D24WT but not TBC1D24F251L promotes arborization of cultured hippocampal neurons. Graph depicts the
average number of neurite termini per cell5 SD from triplicate experiments, with at least 10 neurons counted for each treatment.
(C) Overexpression of TBC1D24WT but not TBC1D24F251L promotes ectopic axonal specification in hippocampal neurons after 5 days’
culture. Graph shows average percentage of transfected cells with multiple axons 5 SD from triplicate experiments, with at least
10 neurons counted for each treatment.
(D) Example images of transfected neurons at 5 days of differentiation, showing either native GFP fluorescence or indirect immunofluo-
rescent staining with Tau1, MAP2, and DAPI, as described. Scale bars represent 100 mM.for GAP activity;14 thus, TBC1D24 may have an alternate
function in the cell, as has been described for TBC1D3.15
The Rab GTPases are known to control neuronal cell
morphology and migration because their mutations have
previously been demonstrated to be deleterious to normal
brain development, such as in OPHN1.16 The TBC1D24
protein has two main domains, the TBC domain (residues
47–262) and the TLD domain (of unknown function; resi-
dues 368–554). TBC1D24may produce up to three protein
isoforms as a result of alternative splicing, and the p.F251L
change is predicted to affect all of these.374 The American Journal of Human Genetics 87, 371–375, SeptembTargeted sequence enrichment and next-generation
sequencing are revolutionizing novel disease gene
discovery. In this case, the technology has allowed us to
take a direct, unbiased and highly effective approach from
phenotype to mutation. The refined linkage interval also
harbors two ion channel genes: CACNA1H (known to
have susceptibility alleles for epilepsy [MIM 607904])17
andCLCN7 (MIM 602727), whichwould have been classed
as plausible candidates over uncharacterized TBC1D24 via
a traditional, positional candidate approach. In humans,
44 TBC domain-containing genes have been identified.18er 10, 2010
Unmasking a defect in TBC1D24, causing epilepsy and ID,
has implicated a member of this large, conserved family of
genes in human disease.Supplemental Data
Supplemental Data include three figures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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